Methamphetamine Use in HIV-infected Individuals Affects T-cell Function and Viral Outcome during Suppressive Antiretroviral Therapy
Marta Massanella(Université de Montréal), Sheldon Morris(University of California, San Diego), Susan J. Little(University of California, San Diego), Davey M. Smith(University of California, San Diego), Michael P. Dubé(University of Southern California), Jennifer M. Dan(La Jolla Institute for Immunology), Sara Gianella(University of California San Diego), Douglas D. Richman(University of San Diego), Constance A. Benson(University of Colorado Health), Eric S. Daar(UCLA Medical Center), Josué Pérez‐Santiago, Michelli F. Oliveira(University of California San Diego), Rachel Schrier(University of California San Diego), Richard Haubrich(University of California San Diego)
Cited by 49
Related Papers
Identification of a Reservoir for HIV-1 in Patients on Highly Active Antiretroviral Therapy
|Science|1997|3.1k
The Efficacy of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related Complex
|New England Journal of Medicine|1987|3k
Antiretroviral Treatment of Adult HIV Infection
|JAMA|2012|2.5k